126 related articles for article (PubMed ID: 28195282)
1. Albumin nanoparticle encapsulation of potent cytotoxic therapeutics shows sustained drug release and alleviates cancer drug toxicity.
Wang H; Wu J; Xu L; Xie K; Chen C; Dong Y
Chem Commun (Camb); 2017 Feb; 53(17):2618-2621. PubMed ID: 28195282
[TBL] [Abstract][Full Text] [Related]
2. Revival of a potent therapeutic maytansinoid agent using a strategy that combines covalent drug conjugation with sequential nanoparticle assembly.
Xie K; Song S; Zhou L; Wan J; Qiao Y; Wang M; Xie H; Zhou L; Zheng S; Wang H
Int J Pharm; 2019 Feb; 556():159-171. PubMed ID: 30553007
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticles Encapsulating Nitrosylated Maytansine To Enhance Radiation Therapy.
Gao S; Zhang W; Wang R; Hopkins SP; Spagnoli JC; Racin M; Bai L; Li L; Jiang W; Yang X; Lee C; Nagata K; Howerth EW; Handa H; Xie J; Ma Q; Kumar A
ACS Nano; 2020 Feb; 14(2):1468-1481. PubMed ID: 31939662
[TBL] [Abstract][Full Text] [Related]
4. A highly potent maytansinoid analogue and its use as a cytotoxic therapeutic agent in gold nanoparticles for the treatment of hepatocellular carcinoma.
Porter J; Ding Y; Hale SJM; Perrins RD; Robinson A; Mazanetz MP; Wu Y; Ma Y; Conlon K; Coulter T
Bioorg Med Chem Lett; 2020 Dec; 30(24):127634. PubMed ID: 33148516
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of anti-RON antibody Zt/g4-drug maytansinoid conjugation (Anti-RON ADC) as a novel therapeutics for targeted colorectal cancer therapy.
Feng L; Yao HP; Wang W; Zhou YQ; Zhou J; Zhang R; Wang MH
Clin Cancer Res; 2014 Dec; 20(23):6045-58. PubMed ID: 25294907
[TBL] [Abstract][Full Text] [Related]
6. Reinvention of chemotherapy: drug conjugates and nanoparticles.
Nguyen-Ngoc T; Raymond E
Curr Opin Oncol; 2015 May; 27(3):232-42. PubMed ID: 25783982
[TBL] [Abstract][Full Text] [Related]
7. Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer.
Junutula JR; Flagella KM; Graham RA; Parsons KL; Ha E; Raab H; Bhakta S; Nguyen T; Dugger DL; Li G; Mai E; Lewis Phillips GD; Hiraragi H; Fuji RN; Tibbitts J; Vandlen R; Spencer SD; Scheller RH; Polakis P; Sliwkowski MX
Clin Cancer Res; 2010 Oct; 16(19):4769-78. PubMed ID: 20805300
[TBL] [Abstract][Full Text] [Related]
8. A Nanosystem of Amphiphilic Oligopeptide-Drug Conjugate Actualizing Both αvβ3 Targeting and Reduction-Triggered Release for Maytansinoid.
Liang Y; Li S; Wang X; He B; He B; Dai W; Zhang H; Wang X; Wang Y; Zhou D; Zhang Q
Theranostics; 2017; 7(13):3306-3318. PubMed ID: 28900511
[TBL] [Abstract][Full Text] [Related]
9. Characterization and preparation of core-shell type nanoparticle for encapsulation of anticancer drug.
Jang MK; Jeong YI; Nah JW
Colloids Surf B Biointerfaces; 2010 Dec; 81(2):530-6. PubMed ID: 20801624
[TBL] [Abstract][Full Text] [Related]
10. Zein nanoparticles as nontoxic delivery system for maytansine in the treatment of non-small cell lung cancer.
Yu X; Wu H; Hu H; Dong Z; Dang Y; Qi Q; Wang Y; Du S; Lu Y
Drug Deliv; 2020 Dec; 27(1):100-109. PubMed ID: 31870183
[No Abstract] [Full Text] [Related]
11. Technology evaluation: C242-DM1, ImmunoGen Inc.
Smith S
Curr Opin Mol Ther; 2001 Apr; 3(2):198-203. PubMed ID: 11338934
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Efficacy and Safety Assessment of an Antibody-Drug Conjugate Targeting the c-RET Proto-Oncogene for Breast Carcinoma.
Nguyen M; Miyakawa S; Kato J; Mori T; Arai T; Armanini M; Gelmon K; Yerushalmi R; Leung S; Gao D; Landes G; Haak-Frendscho M; Elias K; Simmons AD
Clin Cancer Res; 2015 Dec; 21(24):5552-62. PubMed ID: 26240273
[TBL] [Abstract][Full Text] [Related]
13. DM1 Loaded Ultrasmall Gold Nanoparticles Display Significant Efficacy and Improved Tolerability in Murine Models of Hepatocellular Carcinoma.
Hale SJM; Perrins RD; Garcı A CE; Pace A; Peral U; Patel KR; Robinson A; Williams P; Ding Y; Saito G; Rodriguez MÁ; Perera I; Barrientos A; Conlon K; Damment S; Porter J; Coulter T
Bioconjug Chem; 2019 Mar; 30(3):703-713. PubMed ID: 30582799
[TBL] [Abstract][Full Text] [Related]
14. α
Zhong P; Meng H; Qiu J; Zhang J; Sun H; Cheng R; Zhong Z
J Control Release; 2017 Aug; 259():176-186. PubMed ID: 27986551
[TBL] [Abstract][Full Text] [Related]
15. Direct comparison of two albumin-based paclitaxel-loaded nanoparticle formulations: is the crosslinked version more advantageous?
Li C; Li Y; Gao Y; Wei N; Zhao X; Wang C; Li Y; Xiu X; Cui J
Int J Pharm; 2014 Jul; 468(1-2):15-25. PubMed ID: 24709221
[TBL] [Abstract][Full Text] [Related]
16. Endoplasmic reticulum-targeted glutathione and pH dual responsive vitamin lipid nanovesicles for tocopheryl DM1 delivery and cancer therapy.
Wang YQ; Ji MY; Wang C
Int J Pharm; 2020 May; 582():119331. PubMed ID: 32289484
[TBL] [Abstract][Full Text] [Related]
17. Folate receptor-specific antitumor activity of EC131, a folate-maytansinoid conjugate.
Reddy JA; Westrick E; Santhapuram HK; Howard SJ; Miller ML; Vetzel M; Vlahov I; Chari RV; Goldmacher VS; Leamon CP
Cancer Res; 2007 Jul; 67(13):6376-82. PubMed ID: 17616697
[TBL] [Abstract][Full Text] [Related]
18. Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing.
Erickson HK; Park PU; Widdison WC; Kovtun YV; Garrett LM; Hoffman K; Lutz RJ; Goldmacher VS; Blättler WA
Cancer Res; 2006 Apr; 66(8):4426-33. PubMed ID: 16618769
[TBL] [Abstract][Full Text] [Related]
19. Discovery of an SSTR2-Targeting Maytansinoid Conjugate (PEN-221) with Potent Activity in Vitro and in Vivo.
White BH; Whalen K; Kriksciukaite K; Alargova R; Au Yeung T; Bazinet P; Brockman A; DuPont M; Oller H; Lemelin CA; Lim Soo P; Moreau B; Perino S; Quinn JM; Sharma G; Shinde R; Sweryda-Krawiec B; Wooster R; Bilodeau MT
J Med Chem; 2019 Mar; 62(5):2708-2719. PubMed ID: 30735385
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo activity of the maytansinoid immunoconjugate huN901-N2'-deacetyl-N2'-(3-mercapto-1-oxopropyl)-maytansine against CD56+ multiple myeloma cells.
Tassone P; Gozzini A; Goldmacher V; Shammas MA; Whiteman KR; Carrasco DR; Li C; Allam CK; Venuta S; Anderson KC; Munshi NC
Cancer Res; 2004 Jul; 64(13):4629-36. PubMed ID: 15231675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
